TABLE 7.
Peak RFD (Nm/s) 0–100 ms represented as mean ± SD.
| Group | peak RFD (Nm/s) 0–100 ms | Interaction effect | |||||||
| T1 | T2 | 3-way | |||||||
| Pre | Post | 24 h | 48 h | Pre | Post | 24 h | 48 h | ||
| SCP (n = 19) | 2,058 ± 422 | 1,520 ± 336a | 1,587 ± 370a | 1,667 ± 365a | 1,934 ± 402 | 1,794 ± 363*b | 1,912 ± 452* | 1,948 ± 379* |
p < 0.01° (ηp2 = 0.15) |
| PLA (n = 21) | 1,934 ± 297 | 1,637 ± 332a | 1,776 ± 382a | 1,834 ± 381 | 1,862 ± 272* | 1,744 ± 296*b | 1,789 ± 342 | 1,808 ± 330 | |
SCP, specific collagen peptides; PLA, placebo; °, significant 3-way interaction effect. Post-hoc tests: *, significant within groups effect (T1 vs. T2); a, significant within groups effect (T1: pre vs. post, 24 h, 48 h); b, significant within groups effect (T2: pre vs. post, 24 h, 48 h).